Have a personal or library account? Click to login
Treatment outcome of hepatocellular carcinoma patients with high-risk vascular invasion: a retrospective analysis Cover

Treatment outcome of hepatocellular carcinoma patients with high-risk vascular invasion: a retrospective analysis

Asian Biomedicine
Volume 4 (2010): Issue 3 (June 2010)
By: Jade Suphapol,  Boonchoo Sirichindakul,  Bunthoon Nonthasoot and  Supanit Nivatvongs  
Open Access
|Apr 2018

References

  1. 1. Fan J, Zhou J, Wu Z-Q, Qiu S-J, Wang X-Y, Shi Y-H, et al. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2005; 11:1215-9.10.3748/wjg.v11.i8.1215
    Open DOISearch in Google ScholarBack to article
  2. 2. Nowak AK, Chow PK, Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur J Cancer. 2004; 40:1474-84.10.1016/j.ejca.2004.02.027
    Open DOISearch in Google ScholarBack to article
  3. 3. Gotohda N, Kinoshita T, Konishi M, Nakagohri T, Takahashi S, Furuse J, et al. New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement. World J Surg. 2006; 30:431-8.10.1007/s00268-005-0250-3
    Search in Google ScholarBack to article
  4. 4. Bruix J, Sala M, Llovet JM, Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004; 127:179-88.10.1053/j.gastro.2004.09.032
    Search in Google ScholarBack to article
  5. 5. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improved survival. Hepatology. 2003; 37:429-42.10.1053/jhep.2003.50047
    Search in Google ScholarBack to article
  6. 6. O’Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg. 2003; 90:325-31.10.1002/bjs.4045
    Search in Google ScholarBack to article
  7. 7. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985; 56:918-28.10.1002/1097-0142(19850815)56:4<;918::AID-CNCR2820560437>3.0.CO;2-E
    Search in Google ScholarBack to article
  8. 8. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 2000; 31: 840-5.10.1053/he.2000.5628
    Search in Google ScholarBack to article
  9. 9. Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, et al. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005; 92:1862-8.10.1038/sj.bjc.6602590
    Search in Google ScholarBack to article
  10. 10. Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001; 233:379-84.10.1097/00000658-200103000-00012
    Search in Google ScholarBack to article
  11. 11. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural History of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999; 29:62-7.10.1002/hep.510290145
    Search in Google ScholarBack to article
  12. 12. Ohkubo T, Yamamoto J, Sugawara Y, Shimada K, Yamasaki S, Makuuchi M, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg. 2000; 191:657-60.10.1016/S1072-7515(00)00740-7
    Search in Google ScholarBack to article
  13. 13. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005; 137: 403-10.10.1016/j.surg.2004.12.012
    Search in Google ScholarBack to article
  14. 14. Ikai I, Hatano E, Hasegawa S, Fujii H, Taura K, Uyama N, et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the main portal vein. J Am Coll Surg. 2006; 202:431-8.10.1016/j.jamcollsurg.2005.11.012
    Search in Google ScholarBack to article
  15. 15. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362:1907-17.10.1016/S0140-6736(03)14964-1
    Search in Google ScholarBack to article
  16. 16. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology. 1992; 16:112-7.10.1002/hep.1840160119
    Open DOISearch in Google ScholarBack to article
  17. 17. Tzoracoleftherakis EE, Spiliotis JD, Kyriakopoulou T, Kakkos SK. Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma. Hepatogastroenterol. 1999; 46:1122-5.
    Search in Google ScholarBack to article
  18. 18. Yang T-S, Chang H-K, Chen J-S, Lin Y-C, Liau C-T, Chang W-C. Chemotherapy using 5-fluorouracil, mitoxantrone and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. J Gastroenterol. 2004; 39:362-9.10.1007/s00535-003-1303-8
    Search in Google ScholarBack to article
  19. 19. Pawlik TM, Delman KA, Vauthey J-N, Nagorney DM, Ng IO-L, Ikai I, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005; 11:1086-92.10.1002/lt.20472
    Search in Google ScholarBack to article
  20. 20. Ando E, Yamashita F, Tanaka M, Tanikawa K. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer.1997; 79:1890-6.10.1002/(SICI)1097-0142(19970515)79:10<;1890::AID-CNCR8>3.0.CO;2-K
    Search in Google ScholarBack to article
  21. 21. Taieb J, Bonyhay L, Golli L, Ducreux M, Boleslawski E, Tigaud JM, et al. Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules. Cancer. 2003; 98:2664-70.10.1002/cncr.11869
    Open DOISearch in Google ScholarBack to article
  22. 22. Lozano RD, Patt YZ, Hassan MM. Oral capectabine (Xeroda) for the treatment of hepatobiliary cancers (hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer). Proc Annu Meet Am Soc Clin Oncol. 2000; 22:A1407.
    Search in Google ScholarBack to article
  23. 23. Kaneko S, Urabe T, Kobayashi K. Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology. 2002; 62 (Suppl 1): 69-73.10.1159/00004827911868789
    Search in Google ScholarBack to article
  24. 24. Ishikawa T, Ichida T, Sugitani S, Tsuboi Y, Genda T, Sugahara S, et al. Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma. J Gastroenterol Hepatol. 2001; 16:452-9.10.1046/j.1440-1746.2001.02352.x11354285
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/abm-2010-0062 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 491 - 496
Published on: Apr 13, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Hepatocellular carcinoma,
systemic chemotherapy,
transarterial chemoembolization
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2018 Jade Suphapol, Boonchoo Sirichindakul, Bunthoon Nonthasoot, Supanit Nivatvongs, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 4 (2010): Issue 3 (June 2010)Next article